Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
Clinical trial NCT02431221 · WITHDRAWN
Trial details
- NCT number
- NCT02431221
- Sponsor
- Heart Metabolics Limited
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Primary completion
- 2017-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.